ASNC 2025 Scientific Session and Exhibition Meeting OnDemand

ASNC 2025 Scientific Session and Exhibition Meeting OnDemand

The ASNC2025 Annual Scientific Session and Exhibition Meeting OnDemand course will provide you with top-notch education from 27 sessions recorded during the live / virtual meeting September 4-7, and September 13, 2025.

ASNC2025 sets a new benchmark for nuclear cardiology with cutting-edge content, packed sessions, and high energy.

The sessions provided shared valuable insights on disease-based tracks, radiopharmaceutical innovations, and new diagnostic techniques that every nuclear cardiology professional needs to know.

This Meeting OnDemand offers 27 sessions highlighting how nuclear cardiology is expanding rapidly across amyloidosis, artificial intelligence, hybrid imaging, infection, inflammation, molecular imaging, myocardial blood flow quantification, radiopharmaceuticals, sarcoid, and much more.

CME Expiration Date: September 18, 2026*
*CME Credits must be claimed by this date.

This online activity consists of OnDemand lectures recorded from the ASNC2025 sessions. In order to claim CME credits*, you must listen to the recordings and then complete the Evaluation. You can claim credit as you progress through the activity, e.g., watch 2 sessions, claim credit, complete the evaluation, and receive your CME Certificate.

If you watch other presentations and claim credit after completing the evaluation, your CME Certificate will denote the additional credits. This course does not carry ABIM Maintenance of Certification (MOC) points.

*CME Expiration Date: September 18, 2026*

This course is intended for cardiologists, radiologists, nuclear medicine specialists, nuclear technologists, nurses, practice administrators, and other health care professionals with an interest in the field of nuclear cardiology.

At the end of this activity, participants will:

• Demonstrate improved skills in image interpretation and reporting
• Recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
• Identify appropriate use of cardiac imaging techniques based on current guidelines
• Evaluate new imaging technologies, software, and stress techniques
• Identify the role of nuclear and cardiac CT imaging in overall patient care
• Describe the importance of balancing radiation exposure with image quality
• Describe future directions in cardiac PET, CT, and SPECT/CT to anticipate training and equipment needs
• Identify the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology

This activity will increase learners’ competence in solving technical and clinical issues when treating patients with CVD. Sessions present different approaches to cardiac disease management to how to best improve patient outcomes.

These sessions address topics in appropriate use criteria, SPECT best practices, PET best practices, new and emergent cardiac imaging procedures, lab performance and procedures, radiation safety, reporting, and lab performance and the application of appropriate guidelines-based treatments.

To maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria).

Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2025 is an educational activity designed to help imaging professionals on how to best improve outcomes for their patients with CVD.

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this enduring activity for 27 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME.

Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCP) recognizes attendance at continuing education offerings which provide AMA PRA Category 1 Credits™ for the purpose of recertification.

FACULTY/PLANNER/ABSTRACT PRESENTER DISCLOSURES

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit of all its educational activities through the disclosure of all relationships with ineligible companies and mitigation of conflicts of interest.

The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All persons who influenced the content of this activity are required to disclose all relationships. The American Society of Nuclear Cardiology has reviewed these disclosures and resolved or managed all identified conflicts of interest through a peer review process.

The following individuals have nothing to disclose:

• Abadie, Bryan
• Abbott, Brian
• Abohashem, Shady
• Abuzaid, Ahmed
• Adler, Rebecca
• Adomako, Rees
• Agarwal, Vikram
• Ahmed, Ahmed Ibrahim
• Akhter, Afroza
• Al Badarin, Firas
• Al Rifai, Mahmoud
• Albosta, Michael
• Aldajani, Ahmed
• AlJaroudi, Wael
• Aljizeeri, Ahmed
• Alnabelsi, Talal
• Alwan, Maria
• Amin, Rutvi
• Arvind, Shreya
• Asif, Talal
• Atieh, Khaled
• Avery, Ryan
• Azevedo Junior, Giovane
• Azhar, Abdullah Zoheb
• Balasubramanian, Suryakumar
• Barton, Anna
• Bawa, Danish
• Bittar Carlini, Gianfranco
• Blaker, Noah
• Boczar, Kevin
• Bois, John
• Brandão, Simone
• Brandt, Michael
• Bravo, Paco
• Brownell, Kyle
• Budweg, Jeffery
• Bullock-Palmer, Renée
• Cai, Xinzhe James
• Calderon, Laura
• Calnon, Dennis
• Campisi, Roxana
• Carr, Chloe
• Carvajal-Juarez, Isabel
• Chaikijurajai, Thanat
• Charbonne, Gael
• Chen, Lu
• Chidambaram, Vignesh
• Chinnaiyan, Kavitha
• Chiu, Ka Lun
• Chow, Benjamin
• Cremer, Paul
• Crestanello, Juan
• Crofts, Kathy
• Csecs, Ibolya
• Dai, Neng
• de Moraes, Alyssa
• DePuey, E.
• Diaz Mayor, Diego
• DiBlasio, Rebecca
• Ding, Ding
• Divakaran, Sanjay
• Donohue, Joseph
• Doukky, Rami
• Dragomirescu, Catalin
• Duran, Jessica
• Dutta, Joyita
• Duvall, Lane
• Eduardo, Jose
• El Harake, Lamis
• El Mais, Huda
• El Yaman, Ahmad
• ElBallat, Ahmed
• Erba, Paola Anna
• Escobar, Sandra
• Feher, Attila
• Ferreira, Maria Joao
• Gerodias, Ferdinand
• Ghannam, Mohammad
• Giannopoulos, Andreas
• Giarratana, Anna
• Gimelli, Alessia
• Godwin, Lehman
• Gonzalez Sanchez, David
• Gucuk Ipek, Esra
• Hage, Fadi
• Hamandi, Mohanad
• Hansen, Christopher
• Haouzi, Alice
• Hardewig, Iris
• Harinstein, Matthew
• Hart, Paul
• Hasnie, Ammar
• Hazaveh, Sara
• Heidel, R.
• Hendel, Robert
• Higgins, Angela
• Hobocan, Marissa
• Holtz, Daniel
• Horgan, Stephen
• Howladar, Shahad
• Hussain, Wajid
• Hutt, Erika
• Iragavarapu, Shrikar
• Irizarry Berrios, Emanuel
• Jedeon, Zeina
• Jerome, Scott
• Joseph, Lee
• Jouni, Hayan
• Ju, Min
• Juweid, Malik
• Kadoya, Yoshito
• Kadwalwala, Mazhar
• Keating, Friederike
• Khalaf, Shaden
• Khan, Abdul Wali
• Khan, Mahir
• Khan, Mirza
• Kim, Timothy
• Knight, Nicole
• Knight, Stacey
• Kyriakoulis, Ioannis
• Lima, Bruno
• Linscheid, Logan
• Liu, Bolun
• Lopes, Rafael
• Lulu, Cao
• Mackin, Maria
• Madamanchi, Chaitanya
• Maniar, Yash
• Mathew, Jaison
• McCall, Keisha
• Memmott, Matthew
• Mengesha, Bethlehem
• Merani, Maria
• Meretta, Alejandro
• Mishra, Malay
• Modi, Karnav
• Motwani, Manish
• Munshi, Hasan
• Murillo-Garcia, David
• Nielsen, Cybil
• Okafor, Joseph
• Olgun Kucuk, Hilal
• Pavuluri, Swathi
• Perumalla, Sanjana
• Pizzi, María
• Polk, Donna
• Prakash, Sakthi Surya
• Qian, Frank
• Quiram, Benjamin
• Rader, Valerie
• Ramirez, Giselle
• Rasheed, Shazia
• Robles Cruz, Javier Alejandro
• Rodriguez Lozano, Patricia
• Roque, Albert
• Saha, Shubhashis
• Saleem, Mariam
• Santangeli, Pasquale
• Santos Samaritano Pereira, Matheus
• Saunders, Emma
• Schwartz, Ronald
• Sciammarella, Maria
• Shah, Khanjan
• Shanbhag, Aakash Dhananjay
• Shatla, Islam
• Shetty, Mrinali
• Shou, David
• Siddiki, Mikail
• Sivalokanathan, Sanjay
• Slart, Riemer
• Soulek, Diane
• Souza, Sergio
• Ssembajjwe, Brian
• Sterling, Russell
• Suzuki, Yasuyuki
• Tandon, Suman
• Thomas, Gregory
• Thompson, Randall
• Van Decker, William
• Varma, Revati
• Vasilakis, Georgia
• Veeranna, Neal
• Vijayakumar, Shilpa
• Wang, Ke
• Wang, Lei
• Warren, Jaime
• Weinberg, Richard
• Wiefels, Christiane
• Williams, Kim
• Winchester, David
• Woolley, Ann
• Wright, Catherine
• Wright, Donald
• Xie, Boqia
• Yahiro, Davi
• Yamamoto, Atsushi
• Zghyer, Fawzi
• Zhang, Yaqi
• Ziegner, Barbara
• Zohora, Fatema Tuj

The following individuals have provided financial relationships with ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:

• Agarwal, Subhashish – Advisory Board: Pfizer
• Alexander, Kevin – Consulting Fee; Company/Organization; Arbor Biotechnologies, Alexion, Alnylam, BridgeBio, Novo Nordisk, Pfizer
• Alharbi, Jamilah – 2024 ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Award; Pfizer Global
• Al-Mallah, Mouaz – Research Grant: Siemens, GE HealthCare; Consultant: Jubilant, Pfizer, Philips, Medtrace, GE HealthCare
• Arumugam, Parthiban – Speaker Support: Blue Earth DiagNonestics, Ltd, IBA
• Auer, Benjamin – Consulting Fee: Spectrum Dynamics Medical; Research/Grant or Contractor: General Electric Healthcare
• Bateman, Timothy – Advisory Board: GEHC, Synektik; Consulting: GEHC; Intellectual Property Rights, Royalties Ownership Interest; CVIT, LLC
• Benz, Dominik – Advisory Board: Astra Zeneca; Consultant: Pfizer, Astra Zeneca
• Berman, Daniel – Consulting Fee; Bayer Healthcare, GE Healthcare. Royalty; QPS Software Royalties Cedars Sinai. Intellectual property rights; US8885905B2 in USA and WO patent WO2011069120A1, Method and System for Plaque Characterization.
• Blankstein, Ron – Advisory Board: Caristo Inc.; Consulting Fee: Caristo Inc., Nonevartis Inc., NaNonex AI, Amgen Inc., Heartflow Inc.; Research/Grant or Contractor: NaNonex AI, Nonevartis Inc, Amgen Inc., Heartflow Inc
• Bourque, Jamieson – Consultant: GE HealthCare
• Chareonthaitawee, Panithaya – Consultant: GE HealthCare; Royalties: UpToDate
• Clerc, Olivier – Research/Grant or Contractor; Company/Organization; NIH K99 HL175107, International Society of Amyloidosis, American Society of Nuclear Cardiology and Pfizer
• Cuddy, Sarah – Advisory Board; Novo Nordisk, BridgeBio. Advisory Board, Research/Grant or Contractor; Ionis, Astra Zeneca, Alexion. Advisory Board, Research/Grant or Contractor; Astra Zeneca. Research/Grant or Contractor; Alnylam. Honoraria; Pfizer.
• deKemp, Robert – Royalties and Research Funding: Jubilant DraxImage; Sofware License Revenues: INVIA Medical Solutions
• Di Carli, Marcelo – Consulting: IBA, Bitterroot Bio, Valo Health, Sanofi, MedTrace; International Research Grant: Sun Pharma, Gilead Sciences; In-kind Institutional Research Support: Amgen
• Dorbala, Sharmila – Consulting honoraria: Pfizer, Novo Nordisk, Alexion/Astra Zeneca; Research Grant: Pfizer, Attralus, Siemens, Phillips, GE HealthCare
• Dziuk, Miroslaw – Research/Grant or Contractor; Synektik. Advisory Board; Affidea
• Einstein, Andrew – Research Grants: NHLBI, IAEA, Alexion, Attralus, BridgeBio, Canon, GEHC, Intellia, Ionis, Neovasc, Pfizer; Advisory Board: Canon America Medical Systems; Authorship: Wolters Kluwer HC – UpToDate; Consultant: Artya
• Ersözlü, Sara – Research/Grant or Contractor; Amicus Therapeutics. Speakers’ Bureau; Amicus Therapeutics. Advisory Board; Amicus Therapeutics; Travel Support from Alnylam Pharmaceuticals.
• Ferencik, Maros – Advisory Board: Elucid, Cleerly; Consulting Fee: Elucid, Cleerly, HeartFlow, BioMarin; Research/Grant or Contractor: Cleerly; *Stock Interest: Elucid
• Gagliano, Laura – Salaried Employee or Owner; Company/Organization; Jubilant Radiopharma
• Gallegos Kattán, Cesia – Educational Grant: Pfizer; Advisory Board: Pfizer, BridgeBio, Astra Zeneca; Consultant: Pfizer, BridgeBio, Astra Zeneca
• Gropler, Robert – Research/Grant or Contractor; NIH, AHA EIC, Leducq Foundation. Consulting Fee; AHA.
• Grossman, Gabriel – Consulting Fee: Pfizer; Speakers’ Bureau: Pfizer, Nonevartis
• Heller, Gary – Medical Advisor: Molecular Imaging Services
• Huck, Daniel – AHA Career Development Award (23CDA1037589), NIH K23 Career Development Award (1K23HL171893)
• Hyafil, Fabien – Stock Interest: Naogen Pharma; Consultant: Pfizer; Speaker: Curium Pharma, GE HealthCare
• Jaber, Wael – Consultant: Boston Scientific, Pfizer
• Kaviani, Sanaz – Salaried Employee or Owner; Jubilant Radiopharma
• Kersting, David – Research/Grant or Contractor; Pfizer. Consulting Fee; Novartis. Speakers’ Bureau; Pfizer
• Kramer, Christopher – Consulting Fee: Eli Lilly; Research/Grant or Contractor: BMS, Cytokinetics
• Lopez, Diana – Consulting Fee; New Amsterdam
• Maddahi, Jamshid – Research Grant and Consultant: GE HealthCare
• Malhotra, Saurabh – Speaker’s Bureau/Advisory Board: Pfizer, Alnylam; Speaker’s Bureau – AstraZeneca; Consultant: Viz.ai
• Martin, Emily – Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); Attralus, Inc.
• Masri, Ahmad – Research/Grant or Contractor; Pfizer, Ionis, Attralus, Cytokinetics, Janssen. Consulting Fee; Cytokinetics, BMS, BridgeBio, Pfizer, Ionis, Lexicon, Attralus, Alnylam, Haya, Alexion, Akros, Edgewise, Rocket, Lexeo, Prothena, BioMarin, AstraZeneca, Tenaya
• Merlino, Denise – Consultant: Bracco Diagnostics, SNMMI, ASNC, American Geriatrics Society, American Psychiatric Society, American College of Chest Phy, American Thoracic Society
• Miller, Edward – Research Grant – Eidos/BioBridge, Pfizer, Alnylam, Siemens; Consultant – Eidos/BioBridge, Pfizer, Synektik
• Miller, Robert – Research Grant/Consultant – Pfizer
• Moulton, Eric – Salaried Employee or Owner: Jubilant Draxlmage Inc. (dba Jubilant Radiopharma)
• Moura, Filipe – Consultant – Janssen
• Murthy, Venkatesh – Research/Grant or Contractor; Siemens. Consulting Fee; INVIA. *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); General Electric, Cardinal Health, Ionetix. Advisory Board; Ionetix.
• Namías, Mauro – Intellectual property rights; Company/Organization; Mauro Namías and Aley Palau San Pedro are co-inventors of the PCT/PT2022/050033 patent (https://patents
• O’Gorman, Kevin – Ownership/Stock: Abbott Labs, Boston Scientific, Intuitive Surgical Inc, Eli Lilly & Co, Thermo Fischer Scientific, United Health Group, Viking Therapeutics, Doximity
• Osborne, Michael – Consultant: WCG Imaging
• Patel, Krishna – Research Grants – NIH, Jubilant, ACC Geriatric Cardiology Council
• Phillips, Lawrence – Advisory Board: Pfizer; Consulting Fee: Nonevo Nonerdisk, Eli Lilly
• Roby, Amanda – Speakers’ Bureau; Company/Organization; donated all speaking fees and honoraria to UTHealth from Bracco Diagnostics
• Ruddy, Terrence – Research/Grant or Contractor: Canadian Medical Isotope Ecosystem, Pfizer Global, Siemens Healthcare Limited
• Sadeghi, Mehran – Salaried Employee or Owner: Boehringer Ingelheim (spouse employer)
• Saeed, Ibrahim – Consulting Fee; Guidepoint, American Society of Nuclear Cardiology. Advisory Board; BridgeBio
• Sanghani, Rupa – Consultant/Speaker – GE Healthcare
• Saraste, Antti – Advisory Board: Astra Zeneca, Nonevo Nonerdisk, Pfizer; Speakers’ Bureau: Astra Zeneca, Pfizer, Abbott, BMS; Institutional research contracts with Astra Zeneca, New Amsterdam pharma and Precordior
• Shah, Nishant – Research Grant/Advisory Board – Pfizer; Advisory Board – BridgeBio
• Singh, Vasvi – Research grant – ASNC and Pfizer; Speaker’s Bureau – Pfizer, AstraZeneca, Alnylam; Consultant – BridgeBio
• Slomka, Piotr – Software royalties – Cedars Sinai; Consulting – Synektik
• Small, Gary – Honoraria: Pfizer, Alnylam, Jubilant
• Smiley, Dia – Consultant: Alnylam
• Soman, Prem – Research/Grant or Contractor; Company/Organization; Pfizer
• Sorensen, Jens – Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); Company/Organization; Medtrace Pharma A/S
• Sperry, Brett – Consulting Fee; Company/Organization; Pfizer, BridgeBio, Alnylam Pharmaceuticals, AstraZeneca
• Stendahl, John – Other financial benefit; Site principal investigator for clinical research sponsored by Bristol Myers Squibb (no personal compensation received).
• Tang, W. H. Wilson – Consulting Fee: Cardiol Therapeutics, Zehna Therapeutics, GeNonemics plc, Boston Scientific, Bristol Myers Squibb, Alexion Pharmaceuticals
• Tarkin, Jason – Consulting Fee: AstraZeneca; Research/Grant or Contractor: AstraZeneca, SaNonefi
• Tolbod, Lars – Stock Interest: MedTrace Pharma A/S
• Vaishnav, Joban – Advisory Board – Pfizer; Speaker – Alnylam
• Wall, Jonathan – Research/Grant or Contractor; Company/Organization; Attralus, Inc
• Weber, Brittany – Advisory Board; Novo Nordisk, Horizon, Kiniksa.
• Wilcox, Jane – Advisory Board: Abiomed, Cytokinetics, Boerhinger Ingelheim, Abbott, IONIS, FIRE1 Foundry; Consulting Fee: Abiomed, Cytokinetics; Research/Grant or Contractor: Abiomed; Speakers’ Bureau: Boerhinger Ingelheim
• Wolinsky, David – Consultant/Advisory Board – BridgeBio, Alnylam; Consultant – Expert Connect, viz.ai